Jason Pitts

Jason Pitts

No open positions remaining
40 year
Health Technology
Finance
Commercial Services

Profile

Jason Pitts is currently an Independent Director at Seaport Therapeutics, Inc. since 2024 and a Principal at General Atlantic LLC since 2021.
Former roles include Director at Bolt Biotherapeutics, Inc. from 2020 to 2021, Director at CinCor Pharma, Inc. from 2021 to 2023, Director at Third Harmonic Bio, Inc., Principal at Sofinnova Investments, Inc. from 2019 to 2021, Associate at McKinsey & Co., Inc. from 2016 to 2018, and Consultant at Solution Lab, Inc. in 2013.
Education includes undergraduate studies at Cornell University and a doctorate from The Rockefeller University.

Jason Pitts active positions

CompaniesPositionStart
Private Equity Investor 01/03/2021

Former positions of Jason Pitts

CompaniesPositionEnd
CINCOR PHARMA, INC. Director/Board Member 24/02/2023
Private Equity Analyst 01/01/2021
BOLT BIOTHERAPEUTICS, INC. Director/Board Member 01/01/2021
Corporate Officer/Principal 01/01/2018
Consultant / Advisor 01/12/2013
See the detail of Jason Pitts's experience

Training of Jason Pitts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology